Cargando…
A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variants
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) Omicron variant sub-lineages spread rapidly worldwide, mostly due to their immune-evasive properties. This has put a significant part of the population at risk for severe disease and underscores the need for effective anti-SARS-CoV-2 ag...
Ejemplares similares
-
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody
por: Valenzuela Nieto, Guillermo, et al.
Publicado: (2021) -
The distinguishing NS5-M114V mutation in American Zika virus isolates has negligible impacts on virus replication and transmission potential
por: Peng, Nias Y. G., et al.
Publicado: (2022) -
Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of Concern
por: Morgan, Mahali S., et al.
Publicado: (2022) -
Detection and Quantification of SARS-CoV-2 Receptor Binding Domain Neutralization by a Sensitive Competitive ELISA Assay
por: Shalash, Ahmed O., et al.
Publicado: (2021) -
SARS‐CoV‐2 triggers complement activation through interactions with heparan sulfate
por: Lo, Martin W, et al.
Publicado: (2022)